Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.6B |
| FY2017, ended Dec 31, 2017 | $17.4B |
| FY2018, ended Dec 31, 2018 | $36.1B |
| FY2019, ended Dec 31, 2019 | $40.7B |
| FY2020, ended Dec 31, 2020 | $45.0B |
| FY2021, ended Dec 31, 2021 | $52.3B |
| FY2022, ended Dec 31, 2022 | $50.2B |
| FY2023, ended Dec 31, 2023 | $46.2B |
| FY2024, ended Dec 31, 2024 | $43.6B |
| FY2025, ended Dec 31, 2025 | $38.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $44.5B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.44B |
| FY2017, ended Dec 31, 2017 | $6.69B |
| FY2018, ended Dec 31, 2018 | $7.44B |
| FY2019, ended Dec 31, 2019 | $11.1B |
| FY2020, ended Dec 31, 2020 | $11.6B |
| FY2021, ended Dec 31, 2021 | $12.7B |
| FY2022, ended Dec 31, 2022 | $14.1B |
| FY2023, ended Dec 31, 2023 | $14.8B |
| FY2024, ended Dec 31, 2024 | $15.4B |
| FY2025, ended Dec 31, 2025 | $16.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $20.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $847M | $781M |
| FY2017, ended Dec 31, 2017 | $1.08B | $836M |
| FY2018, ended Dec 31, 2018 | $586M | $1.43B |
| FY2019, ended Dec 31, 2019 | $1.25B | $2.14B |
| FY2020, ended Dec 31, 2020 | $1.32B | $2.00B |
| FY2021, ended Dec 31, 2021 | $2.15B | $2.45B |
| FY2022, ended Dec 31, 2022 | $1.44B | $2.48B |
| FY2023, ended Dec 31, 2023 | $2.18B | $904M |
| FY2024, ended Dec 31, 2024 | $1.44B | $1.66B |
| FY2025, ended Dec 31, 2025 | $2.08B | $1.50B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.43B | $1.97B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.79B |
| FY2017, ended Dec 31, 2017 | $90.0M |
| FY2018, ended Dec 31, 2018 | $83.0M |
| FY2019, ended Dec 31, 2019 | $75.0M |
| FY2020, ended Dec 31, 2020 | $240M |
| FY2021, ended Dec 31, 2021 | $567M |
| FY2022, ended Dec 31, 2022 | $535M |
| FY2023, ended Dec 31, 2023 | $267M |
| FY2024, ended Dec 31, 2024 | $510M |
| FY2025, ended Dec 31, 2025 | $1.03B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.52B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.33B |
| FY2017, ended Dec 31, 2017 | $5.10B |
| FY2018, ended Dec 31, 2018 | $15.7B |
| FY2019, ended Dec 31, 2019 | $14.4B |
| FY2020, ended Dec 31, 2020 | $13.5B |
| FY2021, ended Dec 31, 2021 | $11.9B |
| FY2022, ended Dec 31, 2022 | $12.0B |
| FY2023, ended Dec 31, 2023 | $13.2B |
| FY2024, ended Dec 31, 2024 | $15.6B |
| FY2025, ended Dec 31, 2025 | $16.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $30.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 643% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 183M |
| FY2017, ended Dec 31, 2017 | 180M |
| FY2018, ended Dec 31, 2018 | 1.41B |
| FY2019, ended Dec 31, 2019 | 1.41B |
| FY2020, ended Dec 31, 2020 | 1.41B |
| FY2021, ended Dec 31, 2021 | 1.42B |
| FY2022, ended Dec 31, 2022 | 1.41B |
| FY2023, ended Dec 31, 2023 | 1.39B |
| FY2024, ended Dec 31, 2024 | 1.36B |
| FY2025, ended Dec 31, 2025 | 1.36B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.36B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $519M | $45.0M | — | — |
| FY2017, ended Dec 31, 2017 | $399M | $36.0M | — | — |
| FY2018, ended Dec 31, 2018 | — | $35.0M | $9.00B | $441M |
| FY2019, ended Dec 31, 2019 | — | $64.0M | $0 | — |
| FY2020, ended Dec 31, 2020 | $0 | $85.0M | $0 | — |
| FY2021, ended Dec 31, 2021 | $0 | $88.0M | $140M | — |
| FY2022, ended Dec 31, 2022 | $379M | $52.0M | $0 | — |
| FY2023, ended Dec 31, 2023 | $706M | $116M | $0 | — |
| FY2024, ended Dec 31, 2024 | $1.11B | $98.0M | — | — |
| FY2025, ended Dec 31, 2025 | $9.00M | $97.0M | — | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $0 | $114M | — | — |
Valuation
At current price- Market Cap
- $47.4B
- P/E
- 33.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.4×
- Price / Book
- 1.9×
- EV / EBITDA
- 18.7×
Growth
Trailing 12 months- Revenue (TTM)
- $20.1B
- Revenue Growth YoY
- 27.5%
- Revenue CAGR 3Y
- 5.7%
- Revenue CAGR 5Y
- 7.4%
- EPS Growth YoY
- −12.4%
- Net Income Growth YoY
- −7.1%
Profitability
Trailing 12 months- Gross Margin
- 49.4%
- Operating Margin
- 16.2%
- Net Margin
- 7.1%
- FCF Margin
- 9.8%
- Return on Equity
- 5.7%
Earnings
Trailing 12 months- Net Income
- $1.43B
- EPS (diluted)
- $0.99
- EBITDA
- $4.05B
- Operating Income
- $3.26B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.52B
- Total Debt
- $30.0B
- Net Debt
- $28.5B
- Total Assets
- $87.6B
- Total Liabilities
- $54.0B
- Shareholders' Equity
- $25.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.53B
- Capital Expenditure
- $557M
- Free Cash Flow
- $1.97B
Dividends and risk
Last 12 months- Dividend Yield
- 2.6%
- Dividend / Share
- $0.92
- Beta (5Y)
- 0.40
Every ratio is calculated from the company’s reported figures.